- Previous Close
0.0150 - Open
0.0200 - Bid 0.0100 x --
- Ask --
- Day's Range
0.0200 - 0.0200 - 52 Week Range
0.0100 - 0.0800 - Volume
1,500 - Avg. Volume
9,010 - Market Cap (intraday)
2.388M - Beta (5Y Monthly) -0.21
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0700 - Earnings Date Sep 27, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmacology and formulations, pharmaceuticals, cosmetics, and nutraceutical products in Uruguay, Italy, and Poland. The company also engages in the resale of medical supplies products; and sale of medical devices and consumables, and veterinarian products. It offers Cosmetic CBD+CBG. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada.
--
Full Time Employees
October 31
Fiscal Year Ends
Sector
Recent News: RAMM.CN
View MorePerformance Overview: RAMM.CN
Trailing total returns as of 11/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RAMM.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RAMM.CN
View MoreValuation Measures
Market Cap
1.79M
Enterprise Value
529.78k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.40
Price/Book (mrq)
0.07
Enterprise Value/Revenue
0.12
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-198.51%
Return on Assets (ttm)
-13.51%
Return on Equity (ttm)
-30.28%
Revenue (ttm)
4.47M
Net Income Avi to Common (ttm)
-8.87M
Diluted EPS (ttm)
-0.0700
Balance Sheet and Cash Flow
Total Cash (mrq)
1.51M
Total Debt/Equity (mrq)
0.97%
Levered Free Cash Flow (ttm)
-2M